Daphne Stanley

Title: The Innovative Contributions of Daphne Stanley

Introduction

Daphne Stanley is a prominent inventor based in Bethesda, MD, known for her significant contributions to biomedical research. With a focus on developing neutralizing antibodies for the Ebola virus, she has made strides in the field of infectious disease prevention and treatment. Her work has garnered attention for its potential impact on public health.

Latest Patents

Daphne Stanley holds two patents, both centered around neutralizing antibodies to the Ebola virus glycoprotein. These patents disclose antibodies and antigen binding fragments that specifically bind to the Ebola virus glycoprotein. Additionally, they provide nucleic acids encoding these antibodies, vectors, and host cells. The methods outlined in her patents detail how these antibodies and fragments can be utilized to detect the Ebola virus, as well as to prevent and treat infections in affected subjects.

Career Highlights

Throughout her career, Daphne has worked with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and the Institute for Research in Biomedicine. Her experience in these institutions has allowed her to contribute to groundbreaking research and advancements in the field of virology.

Collaborations

Daphne has collaborated with notable colleagues, including Nancy J. Sullivan and Sabue Mulangu. These partnerships have further enhanced her research efforts and expanded the scope of her work in combating viral infections.

Conclusion

Daphne Stanley's innovative work in developing neutralizing antibodies for the Ebola virus highlights her dedication to improving public health through scientific research. Her patents and collaborations reflect her commitment to advancing medical science and finding solutions to critical health challenges.